Print Page  Close Window     


SEC Filings


8-K
VANDA PHARMACEUTICALS INC. filed this Form 8-K on 08/01/2018
Entire Document
 << Previous Page | Next Page >>


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 1, 2018     VANDA PHARMACEUTICALS INC.
    By:   /s/ James P. Kelly
      Name: James P. Kelly
      Title: Executive Vice President, Chief Financial Officer, Treasurer and Secretary
 << Previous Page | Next Page >>